Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Current Oncology (Toronto, Ont.)|February 26, 2026
BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal ImpairmentAlma Habib, Nausheen Ahmed, Abdullah Mohammad Khan, et al.
Frontiers in Oncology|October 24, 2022
Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysisMuhammad Umair Mushtaq, Moazzam Shahzad, Ezza Tariq, et al.
Leukemia & Lymphoma|October 25, 2022
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic reviewMoazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, et al.
Hematology, Transfusion and Cell Therapy|August 11, 2025
Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantationMoazzam Shahzad, Muhammad Kashif Amin, Maggie Nelson, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter AnalysisSruthi P Ramanan, Oyepeju F Abioye, Shebli Atrash, et al.
Leukemia & Lymphoma|February 10, 2022
Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapiesRaheel Sufian Siddiqui, Sibgha Gull Chaudhary, Moazzam Shahzad, et al.
Leukemia & Lymphoma|August 14, 2023
Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipientsJoe S Al-Ramahi, Moazzam Shahzad, Kevin Li, et al.
Transplantation and Cellular Therapy|July 13, 2021
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy RecipientsMuhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, et al.
Hematology, Transfusion and Cell Therapy|November 28, 2025
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxisMuhammad Kashif Amin, Moazzam Shahzad, Abat Khan, et al.
Transfusion|June 7, 2024
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantationMoazzam Shahzad, Muhammad Kashif Amin, Polina Bellman, et al.
Pageof 8